Position in BNTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$137,806
-$4,312 QoQ
Shares Held
1,481
-7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#197
of 282 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 97%
Shared 3%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. BNTX ranks #46 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in BNTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,806 | 1,481 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $142,118 | 1,599 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $162,125 | 1,703 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $184,714 | 1,873 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $203,675 | 1,913 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $205,339 | 2,255 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $360,992 | 3,168 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $555,604 | 4,678 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $2,064,447 | 25,690 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $2,215,566 | 24,017 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $3,019,920 | 28,614 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $596,975 | 5,495 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $613,688 | 5,686 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $626,211 | 5,027 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $701,075 | 4,667 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $678,175 | 5,028 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $807,972 | 5,419 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $748,074 | 4,386 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,045,120 | 4,054 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $793,581 | 2,907 | Shares | Defined | 2021-11-10 | |
| 2021-03-31 | $327 | 3 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $46,221 | 567 | Shares | Defined | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||